181 related articles for article (PubMed ID: 36880049)
1. A novel nano-iron supplement versus standard treatment for iron deficiency anaemia in children 6-35 months (IHAT-GUT trial): a double-blind, randomised, placebo-controlled non-inferiority phase II trial in The Gambia.
Mohammed NI; Wason J; Mendy T; Nass SA; Ofordile O; Camara F; Baldeh B; Sanyang C; Jallow AT; Hossain I; Faria N; Powell JJ; Prentice AM; Pereira DIA
EClinicalMedicine; 2023 Feb; 56():101853. PubMed ID: 36880049
[TBL] [Abstract][Full Text] [Related]
2. A novel nano-iron supplement to safely combat iron deficiency and anaemia in young children: The IHAT-GUT double-blind, randomised, placebo-controlled trial protocol.
Pereira DIA; Mohammed NI; Ofordile O; Camara F; Baldeh B; Mendy T; Sanyang C; Jallow AT; Hossain I; Wason J; Prentice AM
Gates Open Res; 2018; 2():48. PubMed ID: 30569038
[No Abstract] [Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin-guided screen-and-treat interventions for young children with iron-deficiency anaemia in The Gambia: an individually randomised, three-arm, double-blind, controlled, proof-of-concept, non-inferiority trial.
Wegmüller R; Bah A; Kendall L; Goheen MM; Sanyang S; Danso E; Sise EA; Jallow A; Verhoef H; Jallow MW; Wathuo M; Armitage AE; Drakesmith H; Pasricha SR; Cross JH; Cerami C; Prentice AM
Lancet Glob Health; 2023 Jan; 11(1):e105-e116. PubMed ID: 36521942
[TBL] [Abstract][Full Text] [Related]
5. Nutrition-specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews.
da Silva Lopes K; Yamaji N; Rahman MO; Suto M; Takemoto Y; Garcia-Casal MN; Ota E
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013092. PubMed ID: 34564844
[TBL] [Abstract][Full Text] [Related]
6. Hepcidin-guided screen-and-treat interventions against iron-deficiency anaemia in pregnancy: a randomised controlled trial in The Gambia.
Bah A; Muhammad AK; Wegmuller R; Verhoef H; Goheen MM; Sanyang S; Danso E; Sise EA; Pasricha SR; Armitage AE; Drakesmith H; Cross JH; Moore SE; Cerami C; Prentice AM
Lancet Glob Health; 2019 Nov; 7(11):e1564-e1574. PubMed ID: 31607468
[TBL] [Abstract][Full Text] [Related]
7. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
8. Safe and effective delivery of supplemental iron to healthy adults: a two-phase, randomized, double-blind trial - the safe iron study.
Lewis ED; Ortega EF; Dao MC; Barger K; Mason JB; Leong JM; Osburne MS; Magoun L; Nepveux V FJ; Chishti AH; Schwake C; Quynh A; Gilhooly CH; Petty G; Guo W; Matuszek G; Pereira D; Reddy M; Wang J; Wu D; Meydani SN; Combs GF
Front Nutr; 2023; 10():1230061. PubMed ID: 37899826
[TBL] [Abstract][Full Text] [Related]
9. Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age.
Suchdev PS; Jefferds MED; Ota E; da Silva Lopes K; De-Regil LM
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD008959. PubMed ID: 32107773
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of hepcidin-based screen-and-treat approaches using two different doses versus a standard universal approach of iron supplementation in young children in rural Gambia: a double-blind randomised controlled trial.
Wegmüller R; Bah A; Kendall L; Goheen MM; Mulwa S; Cerami C; Moretti D; Prentice AM
BMC Pediatr; 2016 Sep; 16(1):149. PubMed ID: 27585745
[TBL] [Abstract][Full Text] [Related]
11. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants.
Menendez C; Kahigwa E; Hirt R; Vounatsou P; Aponte JJ; Font F; Acosta CJ; Schellenberg DM; Galindo CM; Kimario J; Urassa H; Brabin B; Smith TA; Kitua AY; Tanner M; Alonso PL
Lancet; 1997 Sep; 350(9081):844-50. PubMed ID: 9310602
[TBL] [Abstract][Full Text] [Related]
12. The IHAT-GUT Iron Supplementation Trial in Rural Gambia: Barriers, Facilitators, and Benefits.
Stelle I; McDonagh LK; Hossain I; Kalea AZ; Pereira DIA
Nutrients; 2021 Mar; 13(4):. PubMed ID: 33808403
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
15. Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children: protocol for randomised controlled trial {1}.
Bah M; Verhoef H; Okoh E; Bah A; Prentice AM; Cerami C
Trials; 2024 Apr; 25(1):270. PubMed ID: 38641845
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.
; Carey D; Puls R; Amin J; Losso M; Phanupak P; Foulkes S; Mohapi L; Crabtree-Ramirez B; Jessen H; Kumar S; Winston A; Lee MP; Belloso W; Cooper DA; Emery S
Lancet Infect Dis; 2015 Jul; 15(7):793-802. PubMed ID: 25877963
[TBL] [Abstract][Full Text] [Related]
17. Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan children.
Teshome EM; Andang'o PEA; Osoti V; Terwel SR; Otieno W; Demir AY; Prentice AM; Verhoef H
BMC Med; 2017 Apr; 15(1):89. PubMed ID: 28449690
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
Khalafallah AA; Hyppa A; Chuang A; Hanna F; Wilson E; Kwok C; Yan C; Gray Z; Mathew R; Falloon P; Dennis A; Pavlov T; Allen JC
Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851
[TBL] [Abstract][Full Text] [Related]
19. Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial.
Soofi S; Cousens S; Iqbal SP; Akhund T; Khan J; Ahmed I; Zaidi AK; Bhutta ZA
Lancet; 2013 Jul; 382(9886):29-40. PubMed ID: 23602230
[TBL] [Abstract][Full Text] [Related]
20. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
Dinh A; Ropers J; Duran C; Davido B; Deconinck L; Matt M; Senard O; Lagrange A; Makhloufi S; Mellon G; de Lastours V; Bouchand F; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Renaud B; Perronne C; Claessens YE; Labarère J; Bedos JP; Aegerter P; Crémieux AC;
Lancet; 2021 Mar; 397(10280):1195-1203. PubMed ID: 33773631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
